Skip to main content
. 2022 Aug 31;12(9):1212. doi: 10.3390/biom12091212

Figure 6.

Figure 6

(A) Preparation for immunostaining with anti-TMPRSS2 antibody from skin samples of SARS-CoV-2-positive patients. Note the negativity of the immunolabeling of the epidermal keratinocytes (Immunohistochemistry anti-TMPRSS2, original magnification: 4×). (B) Detail of image A showing negativity of the TMPRSS2 immunolabeling of some adenomeres of eccrine sweat glands. (Immunohistochemistry anti-TMPRSS2, original magnification: 20×).